Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
30,551,628
-
Share change
-
+2,434,547
-
Total reported value
-
$3,353,407,688
-
Put/Call ratio
-
112%
-
Price per share
-
$109.70
-
Number of holders
-
201
-
Value change
-
+$222,326,760
-
Number of buys
-
107
-
Number of sells
-
98
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q1 2021
As of 31 Mar 2021 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,551,628 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., JPMORGAN CHASE & CO, Alua Capital Management LP, MORGAN STANLEY, KPS Global Asset Management UK Ltd, LORD, ABBETT & CO. LLC, and WELLS FARGO & COMPANY/MN.
This table shows 201 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.